SEASONAL ALLERGIC RHINITIS

This study tested a new medicine called LP-003 in 180 adults with moderate to severe seasonal allergies that standard treatments (like antihistamines and nasal sprays) don't fully control. LP-003 is a lab-made antibody that blocks IgE, a key driver of allergic reactions, and is d…

This study looked at whether taking the allergy drug fexofenadine (180 mg) for two days before ragweed season starts can prevent or reduce symptoms like runny nose, sneezing, and itchy eyes. 95 adults with ragweed allergies participated. The goal was to see if early treatment hel…

This early-stage study tested a single dose of MT-2990 in 75 adults with Japanese cedar pollen allergy. Researchers checked safety and how the drug moved through the body, and also measured symptom relief in a special pollen exposure chamber at several time points. The goal was t…

This study tested a drug called omalizumab in 337 adults and teenagers with severe Japanese cedar pollen allergy that standard treatments couldn't control. Participants received either omalizumab or a placebo alongside their usual allergy medicines. The goal was to see if omalizu…

This study tested an investigational injection called TQC2938 in 136 adults with seasonal allergic rhinitis (hay fever). All participants also used a standard nasal spray. The goal was to see if the injection could further reduce nasal symptoms like sneezing and congestion. The t…